Clixit Acne Drying
FDA Label NDC 71328-042
Full FDA labeling including Indications, Dosage, Usage, and Precautions
Structured Product Label
The following Structured Product Label (SPL) was submitted to the FDA by Clixit, Llc for the product Clixit Acne Drying (NDC 71328-042). This document serves as the official prescribing information, containing essential scientific data and clinical materials required for healthcare providers and patients.
This specific version of the label includes detailed information regarding drug facts, active ingredient, purpose, use:, warnings:, otc - keep out of reach of children, directions:, inactive ingredients:, and other regulatory disclosures. Use the navigation below to review specific sections of the FDA submission.
Label Section Quick Index
Active Ingredient
Sulfur 10%
Purpose
Acne Treatment
Use:
For treatment of acne. Healing and drying of acne. Penetrates pores to control acne. Helps prevent breakouts.
Warnings:
For external use only.
Skin irritation and dryness is more likely to occur if you use another topical acne medication at the same time. If irritation occurs, only use one topical acne medication at a time.Stop use and ask a doctor if skin irritation occurs or gets worse. Rinse right away with water if product gets in eyes.
Otc - Keep Out Of Reach Of Children
Keep out of reach of children.
If swallowed, get medical help or call a Poison Control Center right away.
Directions:
DO NOT SHAKE BOTTLE.
Clean the skin thoroughly before using at night. Apply only to areas with acne. Allow solution to dry and rinse off in the morning.
Do not use on broken skin or large areas of skin. If bothersome dryness or peeling occurs, reduce application to every other day.
Inactive Ingredients:
Allantoin, Aqua (Deionized Water), Camphor, Ethylhexylglycerin, Iron Oxide, Isopropyl Alcohol, Magnesium Aluminium Silicate, Phenoxyethanol, Salicylic Acid, Zinc Oxide.
Packaging
Image (7132804201)
* Please review the disclaimer below.
